France· FR:63102506

IDELVION 1000 UI, poudre et solvant pour solution injectable

A albutrepenonacog alfa product containing albutrépénonacog alfa, registered in France by CSL BEHRING (ALLEMAGNE). The same ATC class is registered in 2 of our 19 countries.

ATC B02BD33

Checked against Base de données publique des médicaments — BDPM (France) on September 12, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about albutrépénonacog alfaAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Albutrepenonacog alfa is registered in 2 of 19 countries.

Countries holding a registration under ATC B02BD33 (albutrepenonacog alfa), each read from that country’s own register.

This record: France, from Base de données publique des médicaments — BDPM (France)
1 of them publish a price we can compare per daily dose

Search albutrepenonacog alfa products by name

Albutrepenonacog alfa · ATC B02BD33

2 / 19 countries

Franceprice
United Kingdom

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)

Active substance: ALBUTRÉPÉNONACOG ALFA
Manufacturer: CSL BEHRING (ALLEMAGNE)
Country: France (FR)
ATC code: B02BD33
ATC class: Albutrepenonacog alfa
Defined daily dose: 400 E, P
Reimbursed: No
Source register: Base de données publique des médicaments — BDPM (France)
Last checked: September 12, 2026

Packs & prices · 1

cip13
3400955022800
flacon(s) en verre de 1000 UI - flacon(s) en verre de 2,5 ml avec dispositif(s) de transfert avec filtre(s) avec seringue(s) avec nÃ©cessaire de prÃ©lÃ¨vement avec tampon(s) alcoolisÃ©(s) avec pansement(s)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Albutrepenonacog alfa in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All albutrepenonacog alfa products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

Iceland · Idelvion
Liechtenstein · Idelvion
Norway · Idelvion

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/441e0545-7ea1-4cda-a394-b87669f190a5
GET /v1/drugs/441e0545-7ea1-4cda-a394-b87669f190a5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "63102506",
  "date_amm": "2016-05-11",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/16/1095",
  "substance": "ALBUTRÉPÉNONACOG ALFA",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "poudre et  solvant pour solution injectable",
  "voies_administration": "intraveineuse",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

API reference MCP server Plans

See everything about albutrepenonacog alfa.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console